Infliximab (Remicade) for Patients With Acute Kawasaki Disease

ClinicalTrials.gov ID: NCT00271570

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00271570. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 4:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Infliximab (Remicade) for Patients With Acute Kawasaki Disease Who Fail to Become Afebrile After Intravenous Gamma Globulin Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study evaluates the safety of infliximab in infants and children with acute Kawasaki Disease.

Study identification

NCT ID: NCT00271570
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: University of California, San Diego; Other
Enrollment: 24 participants

Conditions and interventions

Conditions

Kawasaki Disease

Interventions

Infliximab (Remicade) Drug
Intravenous immunoglobulin (IVIG) Biological

Drug · Biological

Eligibility (public fields only)

Age range: Up to 18 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 2004 (Type not available)
Primary completion: Oct 2006 (Actual)
Completion: Oct 2006 (Actual)
Last update posted: Jun 14, 2010

2004 – 2006

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Ucsd/Chhc	San Diego	California	92103	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00271570, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 14, 2010 · Synced Nov 14, 2026